Corteva (NYSE:CTVA) Sets New 12-Month High – Time to Buy?

Shares of Corteva, Inc. (NYSE:CTVA) hit a new 52-week high on Tuesday . The stock traded as high as $77.47 and last traded at $77.4360, with a volume of 197709 shares trading hands. The stock had previously closed at $76.46.

Analysts Set New Price Targets

CTVA has been the topic of several recent analyst reports. Royal Bank Of Canada boosted their price target on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Argus upgraded Corteva to a “strong-buy” rating in a research note on Friday, January 16th. UBS Group lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Mizuho boosted their target price on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 17th. Finally, Rothschild & Co Redburn reduced their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $82.30.

Corteva Trading Up 0.9%

The firm has a 50-day moving average of $70.93 and a 200 day moving average of $68.60. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $51.87 billion, a price-to-earnings ratio of 48.88, a PEG ratio of 2.60 and a beta of 0.75.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same period in the prior year, the firm posted $0.32 earnings per share. The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is presently 45.57%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Activest Wealth Management lifted its position in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC bought a new stake in shares of Corteva during the third quarter valued at approximately $25,000. True Wealth Design LLC raised its position in shares of Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after acquiring an additional 264 shares during the last quarter. Total Investment Management Inc. bought a new position in shares of Corteva in the 2nd quarter valued at about $27,000. Finally, Garton & Associates Financial Advisors LLC acquired a new stake in shares of Corteva during the fourth quarter worth $27,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.